Delivery Order SPE2DB22D1017-SPE2DB25FG4LK
Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,772.76 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on July 25, 2025, with completion expected by July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of pharmaceutical inventory supporting military healthcare operations. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11.84K to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of RINVOQ ER 15 MG tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by May 6, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal...
- The Defense Logistics Agency awarded a delivery order valued at $58,100.78 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on May 5, 2025, with an ultimate completion date of May 6, 2025. This firm fixed price, non-set-aside delivery order represents a purchase of pharmaceutical inventory to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,191.05 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The contract is not set aside and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,111.66 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on July 21, 2025, with a completion date of July 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a small-value pharmaceutical supply transaction. The award was placed of performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order valued at $9,468.74 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price, competitively awarded contract represents a small-value pharmaceutical supply transaction with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $13,070.59 delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitive award utilizes firm fixed pricing with a completion date of June 16, 2025, and carries no set-aside designation. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $15,876.35 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed price contract, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $32,555.23 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $4,684.70 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on June 4, 2025, with completion scheduled for June 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating open competitive award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and this delivery...